Page last updated: 2024-10-26

ebselen and Blood Clot

ebselen has been researched along with Blood Clot in 1 studies

ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.

Research Excerpts

ExcerptRelevanceReference
"In ebselen-pretreated animals (30 mg/kg ip), venular thrombus formation was significantly delayed (50% vessel occlusion: 535+/-34 s; initial stasis: 872+/-82 s; complete occlusion: 908+/-87 s) as compared to vehicle-treated controls (416+/-42; 612+/-49; 647+/-51)."1.32Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression. ( Belusa, L; Lindenblatt, N; Menger, MD; Nickels, RM; Schareck, W; Vollmar, B, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindenblatt, N1
Schareck, W1
Belusa, L1
Nickels, RM1
Menger, MD1
Vollmar, B1

Other Studies

1 other study available for ebselen and Blood Clot

ArticleYear
Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression.
    Thrombosis and haemostasis, 2003, Volume: 90, Issue:5

    Topics: Animals; Antioxidants; Azoles; Blood Platelets; Dose-Response Relationship, Drug; Hydrogen Peroxide;

2003